Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




New Data on Disease-modifying Therapies for Multiple Sclerosis
Link ID 6266
Title New Data on Disease-modifying Therapies for Multiple Sclerosis
Url http://www.medscape.com/viewarticle/575289?src=rss
Description Dr. Mark Tullman discusses results of key clinical trials presented at the 60th annual AAN meeting on currently available disease-modifying therapies for MS and the potential implications.
Medscape Neurology & Neurosurgery
Category Articles > Neurology and Neurosurgery
Keywords
Date May 31, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Neurology and Neurosurgery
1. No Case for Routine Platelet-Function Tests at Present
  More studies linking the effect of antiplatelet drugs on platelet function with clinical outcomes are urgently needed, a new review of the field concludes. Heartwire
Category:   Articles > Neurology and Neurosurgery


2. Tardive Dyskinesia: A Problem That Has Not Gone Away
  Dr. Leslie Citrome discusses a new study comparing the rate of TD between atypical and typical antipsychotics. Medscape Psychiatry & Mental Health
Category:   Articles > Neurology and Neurosurgery


3. Fingolimod Receives FDA Approval as First Oral MS Treatment
  The FDA has approved the drug, which will be marketed by Novartis as Gilenya, to reduce relapses and reduce progression of disability in patients with relapsing-remitting MS. Medscape Medical News
Category:   Articles > Neurology and Neurosurgery


4. Insights into Restless Legs Syndrome: Understanding the Patient Experience to Improve Outcomes
  Drs. Wayne Hening and Jacques Montplaisir discuss the impact of restless legs syndrome on quality of life and the need for accurate diagnosis and long-term management and follow-up to improve outcomes. Medscape Family Medicine
Category:   Articles > Neurology and Neurosurgery


5. FDA Approves Tapentadol for Chronic PainFDA Approves Tapentadol for Chronic Pain
  Tapentadol extended release, already approved for acute pain, has now been given the go ahead for chronic pain. Medscape Medical News
Category:   Articles > Neurology and Neurosurgery




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS